Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study

References

• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2019 Available from: http://www.goldcopd.org/. Accessed 1229, 2018.
   Google Scholar
• BuistAS, VollmerWM, McBurnieMA. Worldwide burden of COPD in high- and low-income countries. Part I. The Burden of Obstructive Lung Disease (BOLD) Initiative. Int J Tuberc Lung Dis. 2008;12(7):703–708.18544191
   PubMed Web of Science ®Google Scholar
• CelliBR, MacNeeW. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946. doi:10.1183/09031936.04.0001430415219010
   PubMed Web of Science ®Google Scholar
• LamprechtB, SorianoJB, StudnickaM, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. doi:10.1378/chest.14-253525950276
   PubMed Web of Science ®Google Scholar
• KocabasA, HanciogluA, TurkyilmazS, et al. Prevalence of COPD in Adana, Turkey (BOLD-Turkey Study). Proc Am Thorac Soc. 2006;3(suppl):A543.
   Google Scholar
• MisirligilZ, CimrinA, GunenH, et al. Real life profile of asthma and chronic obstructive pulmonary disease patients in Turkey. Tuberk Toraks. 2017;65:169–179. doi:10.5578/tt.5406529135394
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011.
   Google Scholar
• WaatevikM, SkorgeTD, OmenaasE, BakkePS, GulsvikA, JohannessenA. Increased prevalence of chronic obstructive pulmonary disease in a general population. Respir Med. 2013;107:1037–1045. doi:10.1016/j.rmed.2013.04.00823680166
   PubMed Web of Science ®Google Scholar
• AllenSC, BaxterM. A comparison of four tests of cognition as predictors of inability to perform spirometry in old age. Age Ageing. 2009;38(5):537–541. doi:10.1093/ageing/afp10419553358
   PubMed Web of Science ®Google Scholar
• Carvalhaes-NetoN, LorinoH, GallinariC, et al. Cognitive function and assessment of lung function in the elderly. Am J Respir Crit Care Med. 1995;152(5):1611–1615. doi:10.1164/ajrccm.152.5.75823037582303
   PubMed Web of Science ®Google Scholar
• WaltersJA, HansenEC, WaltersEH, Wood-BakerR. Underdiagnosis of chronic obstructive pulmonary disease: a qualitative study in primary care. Respir Med. 2008;102(5):738–743. doi:10.1016/j.rmed.2007.12.00818222684
   PubMed Web of Science ®Google Scholar
• MiravitllesM, SorianoJB, Garcia-RioF, et al. Prevalence of COPD in Spain: impact of underdiagnosis COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–868. doi:10.1136/thx.2009.11572519553233
   PubMed Web of Science ®Google Scholar
• YawnBP, WollanPC. Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J Chron Obstruct Pulmon Dis. 2008;3(2):311–317. doi:10.2147/COPD.S248618686740
   PubMedGoogle Scholar
• SorianoJB, ZielinskiJ, PriceD. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721–732. doi:10.1016/S0140-6736(09)61290-319716965
   PubMed Web of Science ®Google Scholar
• CaramoriG, BettoncelliG, TosattoR, et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis. 2005;63(1):6–12. doi:10.4081/monaldi.2005.65116035558
   PubMedGoogle Scholar
• MiravitllesM, de la RozaC, MoreraJ, et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med. 2006;100(11):1973–1980. doi:10.1016/j.rmed.2006.02.02416626950
   PubMed Web of Science ®Google Scholar
• HaldingAG, HeggdalK, WahlA. Experiences of self-blame and stigmatisation for self-infliction among individuals living with COPD. Scand J Caring Sci. 2011;25(1):100–107. doi:10.1111/j.1471-6712.2010.00796.x20534028
   PubMed Web of Science ®Google Scholar
• BruceN, Perez-PadillaR, AlbalakR. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ. 2000;78(9):1078–1092.11019457
   PubMed Web of Science ®Google Scholar
• SalviS, BarnesPJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest. 2010;138(1):3–6. doi:10.1378/chest.10-064520605806
   PubMed Web of Science ®Google Scholar
• GünenH, HacıevliyagilSS, YetkinO, et al. Prevalence of COPD: first epidemiological study of a large region in Turkey. Eur J Intern Med. 2008;19(7):499–504. doi:10.1016/j.ejim.2007.06.02819013377
   PubMed Web of Science ®Google Scholar
• EkiciA, EkiciM, KurtipekE, et al. Obstructive airway diseases in women exposed to biomass smoke. Environ Res. 2005;99(1):93–98. doi:10.1016/j.envres.2005.01.00416053933
   PubMed Web of Science ®Google Scholar
• MahishaleVK, AngadiN, MetgudmathV, et al. The prevalence of chronic obstructive pulmonary disease and the determinants of underdiagnosis in women exposed to biomass fuel in india- a cross section study. Chonnam Med J. 2016;52:117–122. doi:10.4068/cmj.2016.52.2.11727231676
   PubMedGoogle Scholar
• GünenH, YılmazM, AktasO, et al. Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study. Int J Chron Obstruct Pulmon Dis. 2015;10:2485–2494. doi:10.2147/COPD26622176
   PubMed Web of Science ®Google Scholar
• SorianoJB, VisickGT, MuellerovaH, et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128(4):2099–2107. doi:10.1378/chest.128.4.209916236861
   PubMed Web of Science ®Google Scholar
• SinDD, AnthonisenNR, SorianoJB, AgustiAG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.0013380517138679
   PubMed Web of Science ®Google Scholar
• FreiA, MuggensturmP, PutchaN, et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014;67(8):904–911. doi:10.1016/j.jclinepi.2014.03.00524786594
   PubMed Web of Science ®Google Scholar
• MillerJ, EdwardsLD, AgustíA, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107(9):1376–1384. doi:10.1016/j.rmed.2013.05.00123791463
   PubMed Web of Science ®Google Scholar
• SharifR, CuevasCR, WangY, et al. Guideline adherence in management of stable chronic obstructive pulmonary disease. Respir Med. 2013;107(7):1046–1052. doi:10.1016/j.rmed.2013.04.00123639271
   PubMed Web of Science ®Google Scholar
• ŞenE, GüçlüSZ, KibarI, et al. Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey. Int J Chron Obstruct Pulmon Dis. 2015;10:2657–2663. doi:10.2147/COPD.S8532426715844
   PubMed Web of Science ®Google Scholar
• JochmannA, NeubauerF, MiedingerD, et al. General practitioner’s adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Swiss Med Wkly. 2010;140:w13053.
   Web of Science ®Google Scholar
• SeamanJ, LeonardAC, PanosRJ. Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:89–97. doi:10.2147/copd.s882220463890
   PubMedGoogle Scholar
• FitchK, IwasakiK, PyensonB, et al. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis. Curr Med Res Opin. 2011;27:1425–1429. doi:10.1185/03007995.2011.58323021599554
   PubMed Web of Science ®Google Scholar
• MakelaMJ, BackerV, HedegaardM, LarssonK. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490. doi:10.1016/j.rmed.2013.04.00523643487
   PubMed Web of Science ®Google Scholar
• KrigsmanK, NilssonJL, RingL. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf. 2007;16(4):441–448. doi:10.1002/(ISSN)1099-155717006959
   PubMed Web of Science ®Google Scholar
• RestrepoRD, AlvarezMT, WittnebelLD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371–384. doi:10.2147/COPD.S303618990964
   PubMedGoogle Scholar
• ChrystynH, SmallM, MilliganG, et al. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108(2):358–365. doi:10.1016/j.rmed.2013.09.02124209768
   PubMed Web of Science ®Google Scholar
• VestboJ, AndersonJA, CalverleyPM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. doi:10.1136/thx.2009.11366219703830
   PubMed Web of Science ®Google Scholar
• RennardSI, LocantoreN, DelafontB, et al. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE Cohort using cluster analysis. Ann Am Thorac Soc. 2015;12(3):303–312. doi:10.1513/AnnalsATS.201403-125OC25642832
   PubMed Web of Science ®Google Scholar